Laparoscopic sphincter-preserving surgery (intersphincteric resection) after neoadjuvant imatinib treatment for gastrointestinal stromal tumor (GIST) of the rectum
- 10 September 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in International Journal of Colorectal Disease
- Vol. 29 (1), 111-116
- https://doi.org/10.1007/s00384-013-1769-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The Role of Neoadjuvant Imatinib Mesylate Therapy in Sphincter-Preserving Procedures for Anorectal Gastrointestinal Stromal TumorAmerican Journal of Clinical Oncology, 2011
- Neoadjuvant imatinib in a gastrointestinal stromal tumor of the rectum: Report of a caseSurgery Today, 2008
- Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST)Cancer, 2007
- Standardized technique of laparoscopic intracorporeal rectal transection and anastomosis for low anterior resectionSurgical Endoscopy, 2007
- NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice GuidelinesJournal of the National Comprehensive Cancer Network, 2007
- Surgery of Residual Disease Following Molecular-targeted Therapy With Imatinib Mesylate in Advanced/Metastatic GISTAnnals of Surgery, 2007
- Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trialThe Lancet, 2004
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal TumorNew England Journal of Medicine, 2001
- Two Hundred Gastrointestinal Stromal TumorsAnnals of Surgery, 2000